ACCC announces six winners of 2015 Innovator Awards

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

THE ASSOCIATION OF COMMUNITY CANCER CENTERS announced the six winners of its 2015 Innovator Awards.

This year’s winners are:

  • Eastern Maine Medical Center Cancer Program, for improving efficiency, safety and the patient experience with location technology.
  • Lancaster General Hospital and the Ann B. Barshinger Cancer Institute, for creating a Cancer Patient Support Fund for patients experiencing financial distress.
  • Mary Washington Healthcare Regional Cancer Center, for the center’s focused “prehabilitation” program that couples physical therapy with holistic care that includes nutritional support, stress reduction strategies and nurse navigator intervention, which decreased hospital length of stay for thoracic oncology patients by 40 percent.
  • PIH Health Comprehensive Community Cancer Program, for its nurse practitioner-run Lung Cancer Screening Program that utilizes an enrollment method that allows primary care practitioners to refer patients or for the patient to self-refer.
  • Providence Cancer Center, which offers a supportive group model to deliver early and ongoing intervention and support throughout cancer care and creating a framework to talk about the impact of cancer on the family.
  • The Seton Cancer Program of the Seton Family of Hospitals, for developing a standardized, integrated database of clinical and business metrics to measure, analyze and improve patient care and operational efficiency.

More details about each program are available on the ACCC website.

YOU MAY BE INTERESTED IN

Cell and gene therapies have made incredible strides over the past decade. The 2024 FDA approvals of the first T-cell receptor therapy for the treatment of metastatic synovial sarcoma and the first tumor-infiltrating lymphocyte therapy for the treatment of unresectable or metastatic melanoma mark a significant turning point for solid tumor treatment.xxx:more
The intersection of diabetes, obesity and cancer represents an important and underappreciated challenge in medicine. Apart from smoking, overweight is now the leading modifiable risk factor for cancer. With the global epidemic of overweight and diabetes driving cancer incidence across multiple organ sites, understanding the metabolic underpinnings of this relationship has never been more critical.
The Pazdurs in their garden with their dog, Cleo. The dog’s full name is Cleopatra, Queen of Denial.In 1999, Rick Pazdur went in for a “perfunctory” final interview at FDA. Thinking it would only take a few minutes, his wife, Mary, decided to wait and have a quick cup of coffee at a nearby restaurant—Hooters.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login